Logo image
Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling
期刊文章   同儕審查

Atypical chemokine receptor ACKR3/CXCR7 controls postnatal vasculogenesis and arterial specification by mesenchymal stem cells via Notch signaling

Sung-Tai Wei, Yen-Chih Huang, Mei-Ling Hsieh, Yu-Jung Lin, Woei-Cherng Shyu, Hui-Chen Chen 和 Chia-Hung Hsieh
Cell death & disease, 卷.11(5), 頁.307
04/05/2020
PMID: 32366833
Web of Science ID: WOS:000533947600003

摘要

Cell Biology Life Sciences & Biomedicine Science & Technology
Mesenchymal stem cells (MSCs) are known to play a role in postnatal vasculogenesis and hold great promise for vascular regeneration. However, the mechanisms by which the endothelial differentiation and specification of MSCs remain unclear. We examined the potential role and molecular mechanisms of atypical chemokine receptor ACKR3/CXCR7 in MSC-mediated endothelial cell differentiation and specification. Here, we showed that vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) activate CXCR7 expression on MSCs through PDGF receptors, PDGFR alpha and PDGFR beta-mediated phosphoinositide 3-kinase (PI3K)/Akt signaling. Genetic and pharmacologic blockage of CXCR7 on MSCs suppressed the VEGF or stromal cell-derived factor 1 (SDF)-1-induced the capacity for vasculogenesis in vitro and in vivo. Moreover, CXCR7 gain of function markedly promoted vasculogenesis by MSCs in vitro and in vivo and induced endothelial differentiation along the arterial endothelial cell lineage via upregulation of Notch signaling. However, blockade of Notch signaling inhibited CXCR7-induced vasculogensis by MSCs. These results indicate CXCR7 is a critical regulator of MSC-mediated postnatal vasculogenesis and arterial specification via Notch signaling.

檔案與連結 (1)

url
https://doi.org/10.1038/s41419-020-2512-2檢視
已出版(紀錄版本) 開放

相關連結

詳細資料

Logo image